Home NDC 50458-720 PONVORY
Product NDC 50458-720
11-digit product format 504580720
Labeler code 50458
Product ID 50458-720_339b28be-aa00-df1a-e063-6294a90a5453
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Ponesimod
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Janssen Pharmaceuticals, Inc
Application NDA213498
Marketing category NDA
Marketing start 2021-03-18
Marketing end 2027-03-31
Substance PONESIMOD
Active strength 20 mg/1
Pharmacologic classes Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]
NDC exclude flag No
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 10 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N213498-001 PONVORY PONESIMOD 2MG TABLET / ORAL RLD, RS 2021-03-18 N213498-002 PONVORY PONESIMOD 3MG TABLET / ORAL RLD 2021-03-18 N213498-003 PONVORY PONESIMOD 4MG TABLET / ORAL RLD 2021-03-18 N213498-004 PONVORY PONESIMOD 5MG TABLET / ORAL RLD 2021-03-18 N213498-005 PONVORY PONESIMOD 6MG TABLET / ORAL RLD 2021-03-18 N213498-006 PONVORY PONESIMOD 7MG TABLET / ORAL RLD 2021-03-18 N213498-007 PONVORY PONESIMOD 8MG TABLET / ORAL RLD 2021-03-18 N213498-008 PONVORY PONESIMOD 9MG TABLET / ORAL RLD 2021-03-18 N213498-009 PONVORY PONESIMOD 10MG TABLET / ORAL RLD 2021-03-18 N213498-010 PONVORY PONESIMOD 20MG TABLET / ORAL RLD 2021-03-18
Orange Book patents# Current patent rows page 1 of 1 · 50 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N213498-001 RE43728 2029-11-16 Drug substance, Drug product 2021-04-14 N213498-001 9062014 2032-05-06 U-2774 Drug substance, Drug product 2021-04-14 N213498-001 10220023 2035-12-10 U-3103 2021-04-14 N213498-001 12336980 2035-12-10 U-3103 2025-07-08 N213498-001 11951097 2042-10-10 U-3891 2024-05-02 N213498-002 RE43728 2029-11-16 Drug substance, Drug product 2021-04-14 N213498-002 9062014 2032-05-06 U-2774 Drug substance, Drug product 2021-04-14 N213498-002 10220023 2035-12-10 U-3103 2021-04-14 N213498-002 12336980 2035-12-10 U-3103 2025-07-08 N213498-002 11951097 2042-10-10 U-3891 2024-05-02 N213498-003 RE43728 2029-11-16 Drug substance, Drug product 2021-04-14 N213498-003 9062014 2032-05-06 U-2774 Drug substance, Drug product 2021-04-14 N213498-003 10220023 2035-12-10 U-3103 2021-04-14 N213498-003 12336980 2035-12-10 U-3103 2025-07-08 N213498-003 11951097 2042-10-10 U-3891 2024-05-02 N213498-004 RE43728 2029-11-16 Drug substance, Drug product 2021-04-14 N213498-004 9062014 2032-05-06 U-2774 Drug substance, Drug product 2021-04-14 N213498-004 10220023 2035-12-10 U-3103 2021-04-14 N213498-004 12336980 2035-12-10 U-3103 2025-07-08 N213498-004 11951097 2042-10-10 U-3891 2024-05-02 N213498-005 RE43728 2029-11-16 Drug substance, Drug product 2021-04-14 N213498-005 9062014 2032-05-06 U-2774 Drug substance, Drug product 2021-04-14 N213498-005 10220023 2035-12-10 U-3103 2021-04-14 N213498-005 12336980 2035-12-10 U-3103 2025-07-08 N213498-005 11951097 2042-10-10 U-3891 2024-05-02 N213498-006 RE43728 2029-11-16 Drug substance, Drug product 2021-04-14 N213498-006 9062014 2032-05-06 U-2774 Drug substance, Drug product 2021-04-14 N213498-006 10220023 2035-12-10 U-3103 2021-04-14 N213498-006 12336980 2035-12-10 U-3103 2025-07-08 N213498-006 11951097 2042-10-10 U-3891 2024-05-02 N213498-007 RE43728 2029-11-16 Drug substance, Drug product 2021-04-14 N213498-007 9062014 2032-05-06 U-2774 Drug substance, Drug product 2021-04-14 N213498-007 10220023 2035-12-10 U-3103 2021-04-14 N213498-007 12336980 2035-12-10 U-3103 2025-07-08 N213498-007 11951097 2042-10-10 U-3891 2024-05-02 N213498-008 RE43728 2029-11-16 Drug substance, Drug product 2021-04-14 N213498-008 9062014 2032-05-06 U-2774 Drug substance, Drug product 2021-04-14 N213498-008 10220023 2035-12-10 U-3103 2021-04-14 N213498-008 12336980 2035-12-10 U-3103 2025-07-08 N213498-008 11951097 2042-10-10 U-3891 2024-05-02 N213498-009 RE43728 2029-11-16 Drug substance, Drug product 2021-04-14 N213498-009 9062014 2032-05-06 U-2774 Drug substance, Drug product 2021-04-14 N213498-009 10220023 2035-12-10 U-3103 2021-04-14 N213498-009 12336980 2035-12-10 U-3103 2025-07-08 N213498-009 11951097 2042-10-10 U-3891 2024-05-02 N213498-010 RE43728 2029-11-16 Drug substance, Drug product 2021-04-14 N213498-010 9062014 2032-05-06 U-2774 Drug substance, Drug product 2021-04-14 N213498-010 10220023 2035-12-10 U-3103 2021-04-14 N213498-010 12336980 2035-12-10 U-3103 2025-07-08 N213498-010 11951097 2042-10-10 U-3891 2024-05-02
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 10 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 9 · 360 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N213498-001 PONVORY 2MG TABLET / ORAL RLD, RS 2021-03-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-002 PONVORY 3MG TABLET / ORAL RLD 2021-03-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-003 PONVORY 4MG TABLET / ORAL RLD 2021-03-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-004 PONVORY 5MG TABLET / ORAL RLD 2021-03-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-005 PONVORY 6MG TABLET / ORAL RLD 2021-03-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-006 PONVORY 7MG TABLET / ORAL RLD 2021-03-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-007 PONVORY 8MG TABLET / ORAL RLD 2021-03-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-008 PONVORY 9MG TABLET / ORAL RLD 2021-03-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-009 PONVORY 10MG TABLET / ORAL RLD 2021-03-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-010 PONVORY 20MG TABLET / ORAL RLD 2021-03-18 84e616aacf4f…2026-08-18 06:07:40 2026-07 N213498-001 PONVORY 2MG TABLET / ORAL RLD, RS 2021-03-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213498-002 PONVORY 3MG TABLET / ORAL RLD 2021-03-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213498-003 PONVORY 4MG TABLET / ORAL RLD 2021-03-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213498-004 PONVORY 5MG TABLET / ORAL RLD 2021-03-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213498-005 PONVORY 6MG TABLET / ORAL RLD 2021-03-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213498-006 PONVORY 7MG TABLET / ORAL RLD 2021-03-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213498-007 PONVORY 8MG TABLET / ORAL RLD 2021-03-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213498-008 PONVORY 9MG TABLET / ORAL RLD 2021-03-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213498-009 PONVORY 10MG TABLET / ORAL RLD 2021-03-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213498-010 PONVORY 20MG TABLET / ORAL RLD 2021-03-18 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N213498-001 PONVORY 2MG TABLET / ORAL RLD, RS 2021-03-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213498-002 PONVORY 3MG TABLET / ORAL RLD 2021-03-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213498-003 PONVORY 4MG TABLET / ORAL RLD 2021-03-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213498-004 PONVORY 5MG TABLET / ORAL RLD 2021-03-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213498-005 PONVORY 6MG TABLET / ORAL RLD 2021-03-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213498-006 PONVORY 7MG TABLET / ORAL RLD 2021-03-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213498-007 PONVORY 8MG TABLET / ORAL RLD 2021-03-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213498-008 PONVORY 9MG TABLET / ORAL RLD 2021-03-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213498-009 PONVORY 10MG TABLET / ORAL RLD 2021-03-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213498-010 PONVORY 20MG TABLET / ORAL RLD 2021-03-18 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213498-001 PONVORY 2MG TABLET / ORAL RLD, RS 2021-03-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213498-002 PONVORY 3MG TABLET / ORAL RLD 2021-03-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213498-003 PONVORY 4MG TABLET / ORAL RLD 2021-03-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213498-004 PONVORY 5MG TABLET / ORAL RLD 2021-03-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213498-005 PONVORY 6MG TABLET / ORAL RLD 2021-03-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213498-006 PONVORY 7MG TABLET / ORAL RLD 2021-03-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213498-007 PONVORY 8MG TABLET / ORAL RLD 2021-03-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213498-008 PONVORY 9MG TABLET / ORAL RLD 2021-03-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213498-009 PONVORY 10MG TABLET / ORAL RLD 2021-03-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213498-010 PONVORY 20MG TABLET / ORAL RLD 2021-03-18 31067a03dcf5…
Observed Orange Book patent history# Patent history page 1 of 47 · 1,860 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N213498-001 RE43728 2029-11-16 Drug substance, Drug product 2021-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-001 9062014 2032-05-06 U-2774 Drug substance, Drug product 2021-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-001 10220023 2035-12-10 U-3103 2021-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-001 12336980 2035-12-10 U-3103 2025-07-08 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-001 11951097 2042-10-10 U-3891 2024-05-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-002 RE43728 2029-11-16 Drug substance, Drug product 2021-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-002 9062014 2032-05-06 U-2774 Drug substance, Drug product 2021-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-002 10220023 2035-12-10 U-3103 2021-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-002 12336980 2035-12-10 U-3103 2025-07-08 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-002 11951097 2042-10-10 U-3891 2024-05-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-003 RE43728 2029-11-16 Drug substance, Drug product 2021-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-003 9062014 2032-05-06 U-2774 Drug substance, Drug product 2021-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-003 10220023 2035-12-10 U-3103 2021-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-003 12336980 2035-12-10 U-3103 2025-07-08 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-003 11951097 2042-10-10 U-3891 2024-05-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-004 RE43728 2029-11-16 Drug substance, Drug product 2021-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-004 9062014 2032-05-06 U-2774 Drug substance, Drug product 2021-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-004 10220023 2035-12-10 U-3103 2021-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-004 12336980 2035-12-10 U-3103 2025-07-08 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-004 11951097 2042-10-10 U-3891 2024-05-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-005 RE43728 2029-11-16 Drug substance, Drug product 2021-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-005 9062014 2032-05-06 U-2774 Drug substance, Drug product 2021-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-005 10220023 2035-12-10 U-3103 2021-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-005 12336980 2035-12-10 U-3103 2025-07-08 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-005 11951097 2042-10-10 U-3891 2024-05-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-006 RE43728 2029-11-16 Drug substance, Drug product 2021-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-006 9062014 2032-05-06 U-2774 Drug substance, Drug product 2021-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-006 10220023 2035-12-10 U-3103 2021-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-006 12336980 2035-12-10 U-3103 2025-07-08 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-006 11951097 2042-10-10 U-3891 2024-05-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-007 RE43728 2029-11-16 Drug substance, Drug product 2021-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-007 9062014 2032-05-06 U-2774 Drug substance, Drug product 2021-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-007 10220023 2035-12-10 U-3103 2021-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-007 12336980 2035-12-10 U-3103 2025-07-08 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-007 11951097 2042-10-10 U-3891 2024-05-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-008 RE43728 2029-11-16 Drug substance, Drug product 2021-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-008 9062014 2032-05-06 U-2774 Drug substance, Drug product 2021-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-008 10220023 2035-12-10 U-3103 2021-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-008 12336980 2035-12-10 U-3103 2025-07-08 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213498-008 11951097 2042-10-10 U-3891 2024-05-02 84e616aacf4f…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 9 · 360 observed states.
Additional Listing Data#
Finished product Yes
Brand name base PONVORY Active Ingredients# Ingredient, Strength table Ingredient Strength PONESIMOD 20 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 5G7AKV2MKP Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 2 · 22 matching rows.
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 50458-720-30 PONVORY 30 in 1 BOTTLE TABLET, FILM COATED 30 13 50458-720-30 PONVORY 1 in 1 CARTON TABLET, FILM COATED 1 13
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50458-720 PONVORY (PONESIMOD) TABLET, FILM COATED PONVORY (PONESIMOD) KIT [JANSSEN PHARMACEUTICALS, INC] 13 Current NDC, Legacy NDC, 2 package rows 20250427_5be69660-738c-4db7-b0d4-517aa873dc41.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 50458-720-30 50458072030 1 BOTTLE in 1 CARTON (50458-720-30) / 30 TABLET, FILM COATED in 1 BOTTLE 1 bottle 2021-03-18 2027-03-31 No No Current